Shelby D Reed1,2, Jui-Chen Yang1, Matthew J Wallace1

  • 1Duke Clinical Research Institute (S.D.R., J.-C.Y., M.J.W., J.S., F.R.J., S.O., S.M.A.-K.), Duke University School of Medicine, Durham, NC.

概括

患者在新的无心脏起器和传统的透静脉起器之间表现出几乎相等的偏好. 并发症和感染的风险是影响患者选择起器的关键因素.